UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Responder analyses and the assessment of a clinically relevant treatment effect

Trials, 2007-10, Vol.8 (1), p.31-31, Article 31

2007

Volltextzugriff (PDF)

A shrinkage estimator for subgroup analysis without the exchangeability assumption

Journal of biopharmaceutical statistics, 2021-11, Vol.31 (6), p.723-735

Snapinn, Steven

2021

Volltextzugriff (PDF)

Noninferiority trials

Trials, 2000-07, Vol.1 (1), Article 19

Snapinn, Steven M

2000

Volltextzugriff (PDF)

Statins for Secondary Prevention of Cardiovascular Disease: The Right Dose

Pharmacology, 2011-01, Vol.87 (1-2), p.63-69

2011

Volltextzugriff (PDF)

Alternatives for Discounting in the Analysis of Noninferiority Trials

Journal of biopharmaceutical statistics, 2004-12, Vol.14 (2), p.263-273

Snapinn, Steven M.

2004

Volltextzugriff (PDF)

The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study

Journal of the American College of Cardiology, 2005-09, Vol.46 (5), p.770

2005

Volltextzugriff (PDF)

Patient-Identified Most Bothersome Symptom in Patients with Chronic Migraine: An Analysis of PROMISE-2 (541)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial

The American journal of cardiology, 2004-04, Vol.93 (7), p.843-847

2004

Volltextzugriff (PDF)

Pure and Hybrid Causal Effects on Variables Associated with an Incident Event

Journal of biopharmaceutical statistics, 2013-07, Vol.23 (4), p.719-729

2013

Volltextzugriff (PDF)

Informative noncompliance in endpoint trials

Current controlled trials in cardiovascular medicine, 2004-07, Vol.5 (1), Article 5

2004

Volltextzugriff (PDF)

Remaining Challenges in Assessing Non-Inferiority

Therapeutic innovation & regulatory science, 2014-01, Vol.48 (1), p.62-67

2014

Volltextzugriff (PDF)

Separate Modeling Approaches for Survival Analysis with Inaccurate Covariate Measurements

Journal of biopharmaceutical statistics, 2004-12, Vol.14 (2), p.375-387

2004

Volltextzugriff (PDF)

Incorporation of Clinical Meaningfulness Into the Analysis of a Continuous Variable: A More Powerful Alternative to the Responder Analysis

Statistics in biopharmaceutical research, 2014-10, Vol.6 (4), p.349-355

2014

Volltextzugriff (PDF)

Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure

The American journal of cardiology, 2004-03, Vol.93 (5), p.603-606

2004

Volltextzugriff (PDF)

Glycoprotein IIb/IIIa receptor antagonism in patients with acute coronary syndromes and prior coronary artery bypass grafting: Results from PRISM PLUS

Journal of the American College of Cardiology, 2003-03, Vol.41 (6), p.364-364

2003

Volltextzugriff (PDF)

P-644: Health-related quality of life among patients with left ventricular hypertrophy: Baseline characteristics from the life study

American journal of hypertension, 2001-04, Vol.14 (S1), p.245A-245A

2001

Volltextzugriff (PDF)

Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study

The Lancet (British edition), 2003-08, Vol.362 (9384), p.619-620

2003

Volltextzugriff (PDF)

Withdrawal of statins in patients with acute coronary syndromes

Circulation (New York, N.Y.), 2003-01, Vol.107 (3), p.e27-e27

2003

Volltextzugriff (PDF)

1153-73 Moderate alcohol use is associated with reduced cardiovascular risk in patients following complicated acute myocardial infarction

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A417-A418

2004

Volltextzugriff (PDF)

The impact of morbid events on survival following hospitalization for complicated myocardial infarction

European journal of heart failure, 2006-01, Vol.8 (1), p.74-80

2006

Volltextzugriff (PDF)

Snapinn, S. M., Jiang, Q., and Iglewicz, B. (2005), "Illustrating the Impact of a Time-Varying Covariate with an Extended Kaplan-Meier Estimator," "The American Statistician", 59, 301-307: Comment by Beyersmann, Gerds, and Schumacher and Response

The American statistician, 2006-08, Vol.60 (3), p.295-296

2006

Volltextzugriff (PDF)

A history of prior myocardial infarction was independently predictive of mortality but not of recurrent myocardial infarction or heart failure hospitalization in 5477 patients with acute myocardial infarction complicated by cardiac failure

Journal of the American College of Cardiology, 2002-03, Vol.39, p.153-153

2002

Volltextzugriff (PDF)

The interaction between aspirin and losartan on cardiovascular morbidity and mortality in patients with hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) substudy

American journal of hypertension, 2003-05, Vol.16 (5), p.A11-A12

2003

Volltextzugriff (PDF)

Aktive Filter

ThemaMedical Sciences

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(47)
Reviews
(1)

Sprache

Englisch
(48)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Responder analyses and the assessment of a clinically relevant treatment effect

A shrinkage estimator for subgroup analysis without the exchangeability assumption

Noninferiority trials

Statins for Secondary Prevention of Cardiovascular Disease: The Right Dose

Alternatives for Discounting in the Analysis of Noninferiority Trials

The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study

Patient-Identified Most Bothersome Symptom in Patients with Chronic Migraine: An Analysis of PROMISE-2 (541)

Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial

Pure and Hybrid Causal Effects on Variables Associated with an Incident Event

Informative noncompliance in endpoint trials

Remaining Challenges in Assessing Non-Inferiority

Separate Modeling Approaches for Survival Analysis with Inaccurate Covariate Measurements

Incorporation of Clinical Meaningfulness Into the Analysis of a Continuous Variable: A More Powerful Alternative to the Responder Analysis

Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure

Glycoprotein IIb/IIIa receptor antagonism in patients with acute coronary syndromes and prior coronary artery bypass grafting: Results from PRISM PLUS

P-644: Health-related quality of life among patients with left ventricular hypertrophy: Baseline characteristics from the life study

Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study

More on the LIFE study

Withdrawal of statins in patients with acute coronary syndromes

1153-73 Moderate alcohol use is associated with reduced cardiovascular risk in patients following complicated acute myocardial infarction

The impact of morbid events on survival following hospitalization for complicated myocardial infarction

Snapinn, S. M., Jiang, Q., and Iglewicz, B. (2005), "Illustrating the Impact of a Time-Varying Covariate with an Extended Kaplan-Meier Estimator," "The American Statistician", 59, 301-307: Comment by Beyersmann, Gerds, and Schumacher and Response

A history of prior myocardial infarction was independently predictive of mortality but not of recurrent myocardial infarction or heart failure hospitalization in 5477 patients with acute myocardial infarction complicated by cardiac failure

The interaction between aspirin and losartan on cardiovascular morbidity and mortality in patients with hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) substudy

More on the LIFE study

Aktive Filter

Suchergebnisse filtern